Valuation: Encision Inc.

Market Cap 2.19M 1.92M 1.78M 1.64M 3.11M 210M 3.17M 21.36M 8.3M 103M 8.24M 8.06M 357M P/E 2024
-12.5x
P/E 2025 -23.9x
Enterprise Value 3.25M 2.85M 2.63M 2.43M 4.61M 311M 4.7M 31.65M 12.3M 152M 12.21M 11.94M 529M EV / Sales 2024
1.54x
EV / Sales 2025 1.03x
Free-Float
35.96%
Yield 2024 *
-
Yield 2025 -
1 day+114.29%
1 month+400.00%
3 months-98.64%
6 months-99.00%
Current year-98.93%
1 month 0
Extreme 0.0007
0
Current year 0
Extreme 0.0002
0.2
1 year 0
Extreme 0.0002
0.4
3 years 0
Extreme 0.0002
0.75
5 years 0
Extreme 0.0002
1.5
10 years 0
Extreme 0.0002
1.5
Manager TitleAgeSince
Chief Executive Officer 77 2025-12-07
Director of Finance/CFO 42 2024-07-31
Sales & Marketing 51 2022-09-30
Director TitleAgeSince
Director/Board Member 93 1990-12-31
Director/Board Member 77 2024-04-16
Date Insider Type Main position Quantity % Market Cap.
04-14Buy

Chief Executive Officer

166,785 0.9881%
11-17Free

Founder

10,000 0.0592%
11-17Free

VP of Marketing

10,000 0.0592%
Change 5-day change 1-year change 3-year change Capi.($)
+114.29%-.--%-99.59%-99.62% 25.32K
-0.69%+3.25%-28.63%-10.50% 167B
-2.17%+3.55%-7.42%-4.52% 107B
+1.67%+7.33%+3.87%+62.20% 59.24B
+2.86%-3.89%+42.79%+53.48% 52.99B
-3.67%-1.53%-13.78%-41.40% 43.07B
-6.30%-3.43% - - 36.37B
+0.67%+7.55%-11.58%-41.55% 28.39B
-0.67%-3.10%+60.41%-4.82% 25.16B
-1.71%+1.04%-9.80%+4.17% 21.17B
Average +10.43%+41.90%-7.08%-9.17% 54.06B
Weighted average by Cap. -0.96%+2.59%-5.33%+2.55%

Financials

2024 2025
Net sales 6.59M 5.78M 5.33M 4.93M 9.34M 631M 9.53M 64.11M 24.91M 309M 24.73M 24.19M 1.07B 6.56M 5.75M 5.31M 4.91M 9.3M 628M 9.48M 63.81M 24.79M 307M 24.62M 24.08M 1.07B
Net income -692K -607K -560K -518K -981K -66.24M -1M -6.73M -2.62M -32.42M -2.6M -2.54M -113M -220K -193K -178K -165K -312K -21.08M -319K -2.14M -833K -10.32M -827K -809K -35.82M
Net Debt 1.29M 1.13M 1.05M 966K 1.83M 124M 1.87M 12.56M 4.88M 60.48M 4.85M 4.74M 210M 1.06M 927K 856K 791K 1.5M 101M 1.53M 10.29M 4M 49.52M 3.97M 3.88M 172M
Logo Encision Inc.
Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.
Employees
-
  1. Stock Market
  2. Stocks
  3. ECIA Stock